Trial
NCT04833959
Pilot Study of 89-Zr Panitumumab in Pancreas Cancer
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Pancreas Cancer
Intervention
89Zr-panitumumab
Why stopped
Business Decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-06-21